Home › Funds › Defilade Capital Management, L.P. › ORIC

Defilade Capital Management, L.P. position in ORIC

ORIC PHARMACEUTICALS INC · Health Care

Defilade Capital Management, L.P. reported holding 2,272,497 shares of ORIC (ORIC PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$30.6M, representing 5.11% of its reported portfolio and ranking #7 among its reported holdings. Defilade Capital Management, L.P. has disclosed ORIC holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)2.27M sh
Reported value held$30.61M
Portfolio Weight5.11%
First reportedQ1 2026
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Defilade Capital Management, L.P.'s ORIC position evolved

Defilade Capital Management, L.P. first disclosed a stake in ORIC in Q1 2026 at 842,928 shares (US$10.7M). The position peaked in Q3 2026 at 2,272,497 shares, worth US$30.6M. Across 3 filings, Defilade Capital Management, L.P. increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,272,497 shares valued at US$30.6M — an increase of 1,224,807 shares quarter over quarter.. Notable position changes include a 117% increase in Q3 2026 (shares fell 44% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 842.93K $10.68M New
Q2 2026 1.05M $11.35M Add
Q3 2026 2.27M $30.61M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ORIC and 13F data

ORIC (ORIC PHARMACEUTICALS INC) is a Health Care company. 41 other funds we track also report a position in ORIC — the largest reported positions include Nextech Invest Ltd. (US$96.5M), AIHC Capital Management Ltd (US$62.4M), SR ONE CAPITAL MANAGEMENT, LP (US$62.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ORIC

All ORIC fund holders →

FAQ

How long has Defilade Capital Management, L.P. held ORIC?

Defilade Capital Management, L.P. has disclosed ORIC holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Defilade Capital Management, L.P.'s current position in ORIC?

As of Q3 2026, Defilade Capital Management, L.P. holds 2.27M shares of ORIC (ORIC PHARMACEUTICALS INC), valued at $30.61M, representing 5.11% of its reported portfolio and ranking #7.

Has Defilade Capital Management, L.P. been buying or selling ORIC?

In the latest 13F filing (Q3 2026), Defilade Capital Management, L.P. increased its position in ORIC. The position peaked in Q3 2026 at 2.27M shares.

Which other funds hold ORIC?

Other major institutional holders of ORIC include Nextech Invest Ltd., AIHC Capital Management Ltd, SR ONE CAPITAL MANAGEMENT, LP, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.